Related references
Note: Only part of the references are listed.N-Acylethanolamine Acid Amidase contributes to disease progression in a mouse model of multiple sclerosis
Silvia Pontis et al.
PHARMACOLOGICAL RESEARCH (2020)
Pathophysiology and treatment of cerebral edema in traumatic brain injury
Ruchira M. Jha et al.
NEUROPHARMACOLOGY (2019)
Traumatic brain injury in China
Ji-Yao Jiang et al.
LANCET NEUROLOGY (2019)
N-Acylethanolamine acid amidase (NAAA) inhibitor F215 as a novel therapeutic agent for osteoarthritis
Pan Zhou et al.
PHARMACOLOGICAL RESEARCH (2019)
A New Use for an Old Drug: Carmofur Attenuates Lipopolysaccharide (LPS)-Induced Acute Lung Injury via Inhibition of FAAH and NAAA Activities
Kangni Wu et al.
FRONTIERS IN PHARMACOLOGY (2019)
Role of CB2 Receptor in the Recovery of Mice after Traumatic Brain Injury
Lital Magid et al.
JOURNAL OF NEUROTRAUMA (2019)
Hypoxia-Induced MicroRNA-212/132 Alter Blood-Brain Barrier Integrity Through Inhibition of Tight Junction-Associated Proteins in Human and Mouse Brain Microvascular Endothelial Cells
Malgorzata Burek et al.
TRANSLATIONAL STROKE RESEARCH (2019)
Cellular players that shape evolving pathology and neurodegeneration following traumatic brain injury
Shweta S. Puntambekar et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
N-acylethanolamine hydrolyzing acid amidase inhibition: tools and potential therapeutic opportunities
Pauline Bottemanne et al.
DRUG DISCOVERY TODAY (2018)
Inflammation-restricted anti-inflammatory activities of a N-acylethanolamine acid amidase (NAAA) inhibitor F215
Yuhang Li et al.
PHARMACOLOGICAL RESEARCH (2018)
Effect of PEA-OXA on neuropathic pain and functional recovery after sciatic nerve crush
Enrico Gugliandolo et al.
JOURNAL OF NEUROINFLAMMATION (2018)
N-Palmitoylethanolamine-Oxazoline as a New Therapeutic Strategy to Control Neuroinflammation: Neuroprotective Effects in Experimental Models of Spinal Cord and Brain Injury
Daniela Impellizzeri et al.
JOURNAL OF NEUROTRAUMA (2017)
Glibenclamide Attenuates Blood-Brain Barrier Disruption in Adult Mice after Traumatic Brain Injury
Zhi-ming Xu et al.
JOURNAL OF NEUROTRAUMA (2017)
Design and synthesis of uracil urea derivatives as potent and selective fatty acid amide hydrolase inhibitors
Yan Qiu et al.
RSC ADVANCES (2017)
Design, synthesis, and biological evaluation of oxazolidone derivatives as highly potent N-acylethanolamine acid amidase (NAAA) inhibitors
Jie Ren et al.
RSC ADVANCES (2017)
N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition differentially affect N-acylethanolamine levels and macrophage activation
Mireille Alhouayek et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2017)
Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis
Marco Migliore et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Rapid endothelial cytoskeletal reorganization enables early blood-brain barrier disruption and long-term ischaemic reperfusion brain injury
Yejie Shi et al.
NATURE COMMUNICATIONS (2016)
An Important Role for N-Acylethanolamine Acid Amidase in the Complete Freund's Adjuvant Rat Model of Arthritis
F. T. Bonezzi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
A Potent Systemically Active N-Acylethanolamine Acid Amidase Inhibitor that Suppresses Inflammation and Human Macrophage Activation
Alison Ribeiro et al.
ACS CHEMICAL BIOLOGY (2015)
Endocannabinoids modulate human blood-brain barrier permeability in vitro
William H. Hind et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Stretch and/or oxygen glucose deprivation (OGD) in an in vitro traumatic brain injury (TBI) model induces calcium alteration and inflammatory cascade
Ellaine Salvador et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-α
Longhe Yang et al.
SCIENTIFIC REPORTS (2015)
Very Early Administration of Progesterone for Acute Traumatic Brain Injury
David W. Wright et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Traumatic Intracranial Hypertension
Nino Stocchetti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury
Emanuela Esposito et al.
PHARMACOLOGICAL RESEARCH (2014)
Administration of palmitoylethanolamide (PEA) protects the neurovascular unit and reduces secondary injury after traumatic brain injury in mice
Akbar Ahmad et al.
BRAIN BEHAVIOR AND IMMUNITY (2012)
Reduction of ischemic brain injury by administration of palmitoylethanolamide after transient middle cerebral artery occlusion in rats
Akbar Ahmad et al.
BRAIN RESEARCH (2012)
Site-Specific and Time-Dependent Activation of the Endocannabinoid System after Transection of Long-Range Projections
Sonja Kallendrusch et al.
PLOS ONE (2012)
PALMITOYLETHANOLAMIDE REDUCES EARLY RENAL DYSFUNCTION AND INJURY CAUSED BY EXPERIMENTAL ISCHEMIA AND REPERFUSION IN MICE
Rosanna Di Paola et al.
SHOCK (2012)
The endocannabinoid system is modulated in response to spinal cord injury in rats
Daniel Garcia-Ovejero et al.
NEUROBIOLOGY OF DISEASE (2009)
Predominant expression of lysosomal N-acylethanolamine-hydrolyzing acid amidase in macrophages revealed by immunochemical studies
Kazuhito Tsuboi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
The N-acylethanolamine-hydrolyzing acid amidase (NAAA)
Kazuhito Tsuboi et al.
CHEMISTRY & BIODIVERSITY (2007)
Fenofibrate, a peroxisome proliferator-activated receptor α agonist, exerts neuroprotective effects in traumatic brain injury
VC Besson et al.
NEUROSCIENCE LETTERS (2005)
The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide
J Lo Verme et al.
MOLECULAR PHARMACOLOGY (2005)
Massive accumulation of N-acylethanolamines after stroke.: Cell signalling in acute cerebral ischemia?
C Berger et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats
JL Chen et al.
STROKE (2001)
Share Paper
